Investigational New Drugs logo Springer logo

Publisher: Springer

Related content
Volume 19, Number 4, November 2001

all issues

Compatibility and Stability of the Investigational Polypeptide Marine Anticancer Agent Kahalalide F in Infusion Devices
pp. 273-281(9)
Authors: Nuijen, B.; Bouma, M.; Manada, C.; Jimeno, J.M.; Lazaro, L.L.; Bult, A.; Beijnen, J.H.

Gene Expression Profiling of Exposure to TZT-1027, a Novel Microtubule-Interfering Agent, in Non-Small Cell Lung Cancer PC-14 Cells and Astrocytes
pp. 293-301(9)
Authors: Natsume, T.; Nakamura, T.; Koh, Y.; Kobayashi, M.; Saijo, N.; Nishio, K.

A Phase I Trial of the Oral Platinum Analogue JM216 with Concomitant Radiotherapy in Advanced Malignancies of the Chest
pp. 303-310(8)
Authors: George, C.M.; Haraf, D.J.; Mauer, A.M.; Krauss, S.A.; Hoffman, P.C.; Rudin, C.M.; Szeto, L.; Vokes, E.E.

Evaluation of Gemcitabine in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Southwest Oncology Group Phase II Study
pp. 311-315(5)
Authors: Samlowski, W.E.; Gundacker, H.; Kuebler, J.P.; Giguere, J.K.; Mills, G.M.; Schuller, D.E.; Ensley, J.F.

Phase II Trial of Irofulven (6-Hydroxymethylacylfulvene) for Patients with Advanced Renal Cell Carcinoma
pp. 317-320(4)
Authors: Berg, W.J.; Schwartz, L.; Yu, R.; Mazumdar, M.; Motzer, R.J.

Phase II Trial of 9-Aminocamptothecin as a 72-h Infusion in Cutaneous T-Cell Lymphoma
pp. 321-326(6)
Authors: Argiris, A.; Heald, P.; Kuzel, T.; Foss, F.M.; DiStasio, S.; Cooper, D.L.; Arbuck, S.; Murren, J.R.

Phase II Study of Pyrazoloacridine in Metastatic Renal Cell Carcinoma
pp. 327-328(2)
Authors: Kuebler, J.P.; King, G.W.; Triozzi, P.; Moore, T.; Kraut, E.H.

A Phase II Trial of 9-Aminocaptothecin (9-AC) as a 120-h Infusion in Patients with Non-Small Cell Lung Cancer
pp. 329-333(5)
Authors: Vokes, E.E.; Gordon, G.S.; Rudin, C.M.; Mauer, A.M.; Watson, S.; Krauss, S.; Arrieta, R.; Golomb, H.M.; Hoffman, P.C.

Dolastatin-10 in Metastatic Melanoma: A Phase II and Pharmokinetic Trial of the California Cancer Consortium
pp. 335-340(6)
Authors: Margolin, K.; Longmate, J.; Synold, T.W.; Gandara, D.R.; Weber, J.; Gonzalez, R.; Johansen, M.J.; Newman, R.; Baratta, T.; Doroshow, J.H.

Therapeutic Response to Octreotide in Patients with Refractory CPT-11 Induced Diarrhea
pp. 341-343(3)
Authors: Pro, B.; Lozano, R.; Ajani, J.A.

Volume Contents
pp. 345-347(3)

Author Index
pp. 349-350(2)

all issues

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page